New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


The Analyst’s Take: Vision supplements poised for growth

TAGS: General
Claire Morton
With emerging research on the effects of too much screen time, innovation in vision supplements increases growth projections. This is the latest installment of our twice-monthly data discussion from Nutrition Business Journal’s senior analyst.

Americans now spend over 11 hours a day with their eyes glued to a screen, according to Nielsen research. The effects of that blue light exposure on our eye health has been a recent subject of research across the supplements industry.

Due to this renewed focus, previously stagnant vision and eye health supplements are projected to spike in growth through 2019, reaching $554 million annually. Specific ingredients on the rise include lutein, lycopene, astaxanthin, zeaxanthin and meso-zeaxanthin.

See what products are growing in 22 categories, with 109 charts that show sales and growth by condition in the 2017 NBJ Condition Specific Report.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.